BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8762876)

  • 21. The effect of acupuncture on salivary flow rates in patients with xerostomia.
    Blom M; Dawidson I; Angmar-Månsson B
    Oral Surg Oral Med Oral Pathol; 1992 Mar; 73(3):293-8. PubMed ID: 1545961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.
    Jakobsen KK; Carlander AF; Todsen T; Melchiors J; Paaske N; Østergaard Madsen AK; Kloch Bendtsen S; Mordhorst C; Stampe H; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggaard CD; Werner Hauge A; Christensen R; Grønhøj C; von Buchwald C
    Clin Cancer Res; 2024 May; 30(10):2078-2084. PubMed ID: 38441659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies.
    Johnstone PA; Peng YP; May BC; Inouye WS; Niemtzow RC
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):353-7. PubMed ID: 11380221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acupuncture treatment of xerostomia caused by irradiation of the head and neck region: case reports.
    Blom M; Dawidson I; Angmar-Månsson B
    J Oral Rehabil; 1993 Sep; 20(5):491-4. PubMed ID: 10412470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment.
    Guchelaar HJ; Vermes A; Meerwaldt JH
    Support Care Cancer; 1997 Jul; 5(4):281-8. PubMed ID: 9257424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 2 results from Radiation Therapy Oncology Group Study 0537: a phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia.
    Wong RK; James JL; Sagar S; Wyatt G; Nguyen-Tân PF; Singh AK; Lukaszczyk B; Cardinale F; Yeh AM; Berk L
    Cancer; 2012 Sep; 118(17):4244-52. PubMed ID: 22252927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study.
    Garcia MK; Chiang JS; Cohen L; Liu M; Palmer JL; Rosenthal DI; Wei Q; Tung S; Wang C; Rahlfs T; Chambers MS
    Head Neck; 2009 Oct; 31(10):1360-8. PubMed ID: 19378325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
    Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
    Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
    Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
    Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia).
    Sumita Y; Iwamoto N; Seki M; Yoshida T; Honma R; Iwatake M; Ohba S; Takashi I; Hotokezaka Y; Harada H; Kuroshima S; Nagai K; Asahara T; Atsushi Kawakam I; Asahina I
    Medicine (Baltimore); 2020 Jun; 99(26):e20788. PubMed ID: 32590759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
    Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
    Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Questionable validity of the systematic review and meta-analysis by Lovelace et al. on management of radiotherapy-induced salivary hypofunction and xerostomia in patients with oral or head and neck cancer.
    Mercadante V; Lodi G; Porter S; Fedele S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):120-1. PubMed ID: 25482550
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
    Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
    World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
    Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevention and treatment of radiotherapy - induced xerostomia.
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of radiation injuries to the salivary glands after treatment of head and neck cancers].
    Urban A; Miszczyk L; Maciejewski B
    Otolaryngol Pol; 2005; 59(1):21-5. PubMed ID: 15915914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.